Search for: "AMGEN INC."
Results 421 - 440
of 704
Sorted by Relevance
|
Sort by Date
29 Sep 2014, 11:59 am
Amgen, Inc., No. 12-CV-476, 2014 U.S. [read post]
23 Jan 2018, 9:34 am
Amgen, 580 F.3d at 1354. [read post]
19 May 2016, 7:33 pm
Amgen, Inc., 475 F.3d 1256, 1263 (Fed. [read post]
2 Nov 2022, 11:43 am
New Relists Amgen Inc v. [read post]
31 Dec 2023, 4:29 pm
Enablement Amgen v. [read post]
7 Sep 2022, 8:48 am
See Amgen Inc. v. [read post]
29 Sep 2020, 10:23 am
Roche separately patented its own fusion protein, and Immunex (Amgen) effectively purchased this third patent. [read post]
Procrit, Epogen, And Aranesp: New "Black Box" Warnings Only First Part Of FDA's Safety Re-evaluation
12 Mar 2007, 10:10 am
Popular Anemia Drugs Have Increased Risk Of Death, Blood Clots, Strokes, And Heart Attacks, Especially In Context Of Off-label Prescribing And Use (Posted by Tom Lamb at DrugInjuryWatch.com) On March 9, 2007 the FDA announced that Amgen Inc. and Johnson & Johnson (J&J) would add strong new warnings to their anemia drugs Procrit, Epogen, and Aranesp after several recent studies showed a higher risk of death and life-threatening side effects in some patients. [read post]
1 Mar 2014, 8:55 pm
Barr Laboratories, Inc., 40 F. 3D 1223, 1229 (Fed. [read post]
12 Mar 2013, 8:03 am
Amgen Inc., et al. v. [read post]
16 Jan 2017, 5:44 pm
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 Sep 2016, 6:03 pm
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
17 May 2024, 9:37 pm
Although not directly related, the Supreme Court’s May 18, 2023 decision in Amgen v. [read post]
28 Sep 2020, 8:00 am
EMD Serono, Inc. [read post]
14 Dec 2021, 9:57 am
Dropbox, Inc., No. 21-812. [read post]
27 Aug 2012, 6:11 am
Ct. 1414 (2012)--relating to the statute of limitations under Section 16 of the Securities and Exchange Act of 1934, and granted review in two other cases--Amgen, Inc. v. [read post]
27 Aug 2012, 6:11 am
Ct. 1414 (2012)--relating to the statute of limitations under Section 16 of the Securities and Exchange Act of 1934, and granted review in two other cases--Amgen, Inc. v. [read post]
4 Jan 2008, 11:12 am
- Corporate tax partner David Mansell of Mercer & Hole in the English accounting firm's SME Plus Blog New Pension Protection Act rules can make two retirement plans better than one - Retirement planning specialist Jerry Kalish of National Benefit Services Inc. in his Retirement Plan Blog Visionary Sheldon Bonovitz steps down at Duane Morris - Legal marketing expert Larry Bodine in his Law Marketing Blog Appearance on the Paul Gallo Radio Show on Monday - Portland… [read post]
2 Jan 2013, 5:00 am
Behrend, No. 11-864 (argued Nov. 5, 2012) Amgen Inc. v. [read post]
12 Apr 2017, 5:00 am
Court of Appeals for the Second District affirmed the district court's judgment, finding the allegations “wholly conclusory and materially indistinguishable from the allegations that the Supreme Court found insufficient” in Amgen Inc. v. [read post]
